A SINGLE-DOSE, 2-ARM, PHARMACOKINETIC STUDY OF PF-06439535 (CN) AND EUROPEAN UNION SOURCED BEVACIZUMAB IN CHINESE HEALTHY MALE VOLUNTEERS

NCT04126044 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The study was withdrawn prior to enrollment after a comprehensive review of the biosimilars market and the company's global manufacturing network.

Conditions

Interventions

Sponsor

Pfizer